乳腺癌患者注射紫杉醇会影响月经吗?

2021-07-07 MedSci原创 MedSci原创

乳腺癌患者注射紫杉醇会影响月经吗?

《梅斯直播课:3天乳腺癌诊疗训练营》
06.25-年轻乳腺癌的治疗要点及生育管理
回答问题8:患者是第六次化疗,打了紫杉醇,月经推后了一星期了,请问,打了紫杉醇会影响月经吗?

 

欢迎点赞、评论、分享

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=998052, encodeId=17df99805210, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jul 09 19:09:18 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376825, encodeId=719213e68255a, content=<a href='/topic/show?id=f8216055671' target=_blank style='color:#2F92EE;'>#月经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60556, encryptionId=f8216055671, topicName=月经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571268, encodeId=a73815e1268b1, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997312, encodeId=a78299e31273, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:20:09 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-09 医鸣惊人

    认真学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=998052, encodeId=17df99805210, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jul 09 19:09:18 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376825, encodeId=719213e68255a, content=<a href='/topic/show?id=f8216055671' target=_blank style='color:#2F92EE;'>#月经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60556, encryptionId=f8216055671, topicName=月经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571268, encodeId=a73815e1268b1, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997312, encodeId=a78299e31273, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:20:09 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-09 luwei00

    #月经#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=998052, encodeId=17df99805210, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jul 09 19:09:18 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376825, encodeId=719213e68255a, content=<a href='/topic/show?id=f8216055671' target=_blank style='color:#2F92EE;'>#月经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60556, encryptionId=f8216055671, topicName=月经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571268, encodeId=a73815e1268b1, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997312, encodeId=a78299e31273, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:20:09 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=998052, encodeId=17df99805210, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jul 09 19:09:18 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376825, encodeId=719213e68255a, content=<a href='/topic/show?id=f8216055671' target=_blank style='color:#2F92EE;'>#月经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60556, encryptionId=f8216055671, topicName=月经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571268, encodeId=a73815e1268b1, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997312, encodeId=a78299e31273, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:20:09 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-07 机智哈

    学习一下

    0

相关资讯

年轻乳腺癌的肿瘤特征是什么?复发风险和预后有何特点?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

BRCA1/2突变的年轻患者是否适宜保乳手术?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

阳性且有转移的乳腺癌患者是只能注射靶向药治疗吗?

《梅斯直播课:3天乳腺癌诊疗训练营》 06.25-年轻乳腺癌的治疗要点及生育管理 回答问题6:阳性且有转移的治疗是只能一直打靶向药么?

年轻乳腺癌ofs+AI后仍未绝经,后续如何进行内分泌治疗?

年轻乳腺癌ofs+AI后仍未绝经,后续如何内分泌治疗?

年轻乳腺癌应选择乳房切除术还是保乳手术?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

拓展阅读

紫杉醇疗效关键,最新Nature大子刊!

本研究针对β3‑微管蛋白介导紫杉醇耐药这一临床关键问题,整合生物膜干涉、单分子荧光显微、近原子分辨率冷冻电镜与CRISPR基因编辑技术。

「不用输液」的化疗来了?顶刊证实:口服紫杉醇疗效媲美静脉注射,乳腺癌或迎来居家治疗新时代!

这项跨国多中心研究首次证实,新型口服紫杉醇制剂DHP107,在治疗HER2阴性复发或转移性乳腺癌时,其疗效非劣效于经典的每周静脉紫杉醇方案,且安全性特征互补。

新型紫杉醇难改晚期胆道肿瘤预后!JAMA子刊:三药方案未超吉西他滨 + 顺铂双药标准

最新多中心III期RCT显示,吉西他滨+顺铂基础上加入紫杉醇聚合物胶束未能改善晚期胆道肿瘤患者的生存结局,强化化疗策略面临挑战。

论文解读│METTL3通过CASP9/BIRC3依赖的凋亡途径促进食管鳞癌进展并降低对紫杉醇的化疗敏感性

该研究首次揭示了METTL3通过调控m6A甲基化修饰影响CASP9和BIRC3的mRNA稳定性,进而促进食管鳞癌细胞增殖、迁移,并降低对紫杉醇的化疗敏感性的机制。

Adv Sci:长春工业大学郑敏等团队通过将碳点与紫杉醇前药组装,研究开发了一种诊疗平台

该研究通过将碳点(CD)与紫杉醇前药组装,开发了一种诊疗平台(CDSP NPs)。

优化现有方案PFS延长约3个月,疾病控制率85%!《柳叶刀》子刊:或为晚期胃癌患者带来新选择

该研究展示出紫杉醇联合雷莫西尤单抗作为一线转换维持方案的疗效和安全性,这种转换维持策略或可作为一种潜在的治疗选择。